Volume | 10,278 |
|
|||||
News | - | ||||||
Day High | 11.22 | Low High |
|||||
Day Low | 10.74 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
iTeos Therapeutics Inc | ITOS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
11.00 | 10.74 | 11.22 | 10.99 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
236 | 10,278 | $ 10.90 | $ 112,037 | - | 8.20 - 18.24 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
10:51:50 | 1 | $ 10.75 | USD |
iTeos Therapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
390.33M | 35.84M | - | 12.6M | -112.64M | -3.14 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
iTeos Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ITOS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 11.15 | 11.22 | 10.01 | 10.64 | 366,676 | -0.40 | -3.59% |
1 Month | 12.73 | 13.80 | 10.01 | 12.17 | 319,504 | -1.98 | -15.55% |
3 Months | 9.95 | 13.80 | 9.70 | 11.32 | 290,257 | 0.80 | 8.04% |
6 Months | 9.08 | 13.80 | 8.7301 | 10.75 | 304,076 | 1.67 | 18.39% |
1 Year | 13.75 | 18.24 | 8.20 | 11.79 | 360,408 | -3.00 | -21.82% |
3 Years | 24.03 | 52.43 | 8.20 | 21.48 | 364,521 | -13.28 | -55.26% |
5 Years | 19.70 | 52.43 | 8.20 | 22.64 | 333,465 | -8.95 | -45.43% |
iTeos Therapeutics Description
ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody. |